Tharimmune Inc (THAR)
0.3651
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.3651
0.00 (0.00%)
After-Hours: 20:00
Tharimmune Shareholders Equity (Quarterly): 7.049M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.049M |
| December 31, 2023 | 9.131M |
| September 30, 2023 | 1.757M |
| June 30, 2023 | 3.069M |
| March 31, 2023 | 3.201M |
| December 31, 2022 | 5.544M |
| September 30, 2022 | 7.116M |
| Date | Value |
|---|---|
| June 30, 2022 | 9.040M |
| March 31, 2022 | 10.34M |
| December 31, 2021 | -4.685M |
| September 30, 2021 | -7.145M |
| June 30, 2021 | -6.296M |
| December 31, 2020 | -3.718M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-7.145M
Minimum
Sep 2021
10.34M
Maximum
Mar 2022
2.646M
Average
3.201M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | -330.52M |
| Mirum Pharmaceuticals Inc | 234.60M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.887M |
| Total Liabilities (Quarterly) | 1.838M |